Eyewear giants Essilor, Luxottica to merge

Italian eyewear maker Luxottica (NYSE:LUX) and France’s leading lens manufacturer, Essilor (EPA:EI), have reached a €46 billion ($49 billion) agreement to merge and create a global eyewear company with annual revenue of more than €15 billion. “Finally … two products which are naturally complementary—namely frames and lenses—will be designed, manufactured and distributed under the same

Bruker expands through InVivo Biotech Services acquisition

Bruker has acquired InVivo Biotech Services (Hennigsdorf, Germany), the companies announced Wednesday. The finances of the deal were not disclosed. Bruker hopes to expand its microbiology assay with this acquisition. Bruker currently has an assay for fast identification of bacteria from positive blood cultures, the MALDI Biotyper, and hopes to expand it using InVivo Biotech’s

Steady as she goes: M&A experts weigh in on what is changing (and what isn’t)

M&A experts have some good news for medtech startups: Large companies’ appetites for acquiring new companies and technologies remains reliable as ever. Device Talks, which was held in Newport Beach, Calif., last week, featured a panel of M&A experts including advisors from Greenberg Traurig, Caldera Medical Group, Cerus and Locust Walk. The group discussed overall M&A in

Cosmed Group acquires ethylene oxide sterilization operation

Cosmed Group has bought an ethylene oxide sterilization operation from iuvo BioScience, ending an 12-year break from the marketplace. Ethylene oxide (ETO) is a colorless, flammable and explosive gas that is used as a low-temperature sterilant, according to a 2008 Disinfection and Sterilization Guideline article relayed by the CDC. Alkylation contributes to the microbicidal activity

Chinese biotech investor VIROAD takes over GILUPI

The investors AURELIA, High-Tech Gründerfonds (HTGF), KfW, ILB, the – venture capital fund of the Sparkassen of Brandenburg and Business Angels, sold their GILUPI shares to the strategic partner VIROAD. GILUPI is a company developing and manufacturing personalized cancer diagnostics in Potsdam. Due to the takeover, GILUPI gets the opportunity to continue the development of

SMC expands drug delivery capabilities with Oval Medical Technologies acquisition

SMC, a global contract manufacturer of pharmaceutical and finished medical devices, announced that it has acquired Oval Medical Technologies, a specialty pharmaceutical device company developing next generation autoinjectors based in Cambridge, U.K. Oval’s autoinjector platforms address the unmet needs in the self-injection market utilizing both cyclic olefin plastic and glass primary drug containers. Their autoinjectors

Avantor unveils new brand identity

Avantor Performance Materials introduced a new corporate logo and visual identity. The change comes two months after Avantor merged with NuSil Technology to form a growing, global supplier of ultra-high-purity life sciences and advanced technologies materials with strict regulatory and performance specifications. “Following the merger of Avantor and NuSil Technology, we needed to give our

Switzerland’s SFS Group to acquire contract manufacturer Tegra Medical

Swiss fastening system component manufacturer SFS Group said today it is acquiring contract manufacturer Tegra Medical for an undisclosed amount. Tegra Medical will continue to operate under the Tegra Medical brand, with headquarters remaining in Franklin, Mass. Current CEO J. Mark King, CFO Craig Campbell, sales & marketing VP Lee Crowe and Genesis Tech Center VP Mike

Fresenius Medical Care acquires XENIOS AG

XENIOS is driving innovation in minimally invasive lung and heart assist, and is first to offer a complete product range that runs on a common platform. Fresenius Medical Care is a global market leader in dialysis, an extracorporeal medical procedure offering multiple analogies to lung support technologies. In the field of dialysis Fresenius Medical Care

Inside the largest medical device acquisition in history

In June 2014, Medtronic and Covidien shook the medical technology industry with the announcement of a merger of unprecedented scale. OCTANe’s Medical Investor Forum, held in Irvine, Calif., Oct. 27-28, featured a conversation between Geoff Martha, who led Medtronic’s team for the $50 billion merger, and Brett Wall, former president of Covidien and current president

Molex completes acquisition of Phillips-Medisize Corporation

Molex, a global manufacturer of complete interconnect solutions, has completed its previously announced acquisition of Phillips-Medisize Corporation, a portfolio company of the San Francisco, CA -based private equity investment firm, Golden Gate Capital. Phillips-Medisize will operate as an indirect subsidiary of Molex, LLC. Financial terms of the transaction were not disclosed. “Phillips-Medisize brings strong capabilities

Healthcare IT VC funding reaches $1.25 billion in Q3 2016 reports Mercom Capital Group

Mercom Capital Group, a global communications and research firm, released its report on funding and mergers and acquisitions (M&A) activity for the Healthcare Information Technology (IT)/Digital Health sector for the third quarter of 2016. Mercom’s comprehensive report covers deals of all sizes across the globe. Venture capital (VC) funding in the Health IT sector, including

ARC Group worldwide announces sale of non-core division

ARC Group Worldwide, a global provider of advanced manufacturing and 3D printing solutions, announced the completion of the sale of Tekna Seal LLC, a non-core subsidiary of ARC, for $10.5 million USD. “Tekna Seal is a great business with a strong team,” said ARC CEO, Jason Young. “While we are disappointed it will no longer

Hamilton Thorne picks up Embryotech Labs for $7m

Laser device and imaging analysis maker Hamilton Thorne said today it picked up Massachusets-based Embryotech Laboratories for $7.25 million. Embryotech provides quality-control testing services and materials for assisted reproductive technologies, providing quality control testing services and toxicity detection to manufacturers of growth media, labware, disposables and other devices that come into contact with gametes or

Effectus clinical trial recruitment services announces launch

The MJM Signature Group is pleased to announce the launch of Effectus, a clinical trial recruitment company which will join Spire Learning and CPE Communications as a new division. Effectus has developed a unique approach to patient recruitment by working directly with targeted, pre-screened physicians who have signed on and are committed to the Effectus